Clinical Trials Browser

OTHER_GOV × Small Cell Lung Carcinoma × Irinotecan × Clear all

NCT05595889 2022-11-29

Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT00452634 2013-06-19

Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)

Phase 2 Completed

Small Cell Lung Carcinoma